Glyburide Tablet
Product Images NDC 71209-009

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 71209-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cadila Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container-label-1000s-count-1-25mg.jpg (Container Label 1000s Count 1 25mg)

GlyBURIDE Tablets, USP 1.25 mg oral tablets label showing dosage strength, package size of 1000 tablets, and labeler Cadila Pharmaceuticals Limited. The label includes storage instructions, a barcode, and a statement indicating prescription use only (Rx only).*

FDA Label Image

Container-label-1000s-count-2-5mg.jpg (Container Label 1000s Count 2 5mg)

Label of Glyburide Tablets, USP 2.5 mg oral tablets by Cadila Pharmaceuticals Limited. The label indicates 1000 tablets per container, with storage instructions, manufacturing details, and a barcode. It states the product is prescription-only and includes a space for serialized data matrix and batch coding.*

FDA Label Image

Container-label-1000s-count-5mg.jpg (Container Label 1000s Count 5mg)

Label for Glyburide Tablets, USP 5 mg oral tablets by Cadila Pharmaceuticals Limited. The label includes dosage instructions, storage conditions, manufacturer address, and a barcode. The package contains 1000 tablets marked Rx only.*

FDA Label Image

Container-label-100s-count-1-25mg.jpg (Container Label 100s Count 1 25mg)

Label for GlyBURIDE Tablets, USP 1.25 mg oral tablets by Cadila Pharmaceuticals Limited. The label indicates 100 tablets per container, with usage and storage instructions, a barcode, and a note for serialized datamatrix code and batch coding area. The product is marked Rx only and includes manufacturer details.*

FDA Label Image

Container-label-100s-count-2-5mg.jpg (Container Label 100s Count 2 5mg)

GlyBURIDE Tablets, USP 2.5 mg oral tablets, packaged by Cadila Pharmaceuticals Limited. The label indicates a quantity of 100 tablets per container. The label includes storage instructions, usage directions referencing accompanying literature, and a barcode with the NDC 71209-010-05. Additional manufacturing details and safety warnings are also present.*

FDA Label Image

Container-label-100s-count-5mg.jpg (Container Label 100s Count 5mg)

Glyburide Tablets, USP 5 mg oral tablets packaging label from Cadila Pharmaceuticals Limited. The label indicates 100 tablets per container, with storage instructions and a caution to keep out of reach of children. The NDC 71209-011-05 is visible alongside dosage and manufacturer details.*

FDA Label Image

Container Label 500s Count 2 5mg

Sticker label for Glyburide Tablets, USP 2.5 mg by Cadila Pharmaceuticals Limited. The label states the quantity as 500 tablets. It includes storage instructions, dosage advice directing users to accompanying literature, and warnings to keep medication out of reach of children. The label displays a barcode and manufacturing details linked to Cadila Pharmaceuticals in Ahmedabad, India.*

FDA Label Image

Container Label 500s Count 5mg

Sticker label for Glyburide Tablets USP, 5 mg strength. The label indicates the product contains 500 tablets, is for prescription use only, and is manufactured by Cadila Pharmaceuticals Limited in Ahmedabad, Gujarat, India. Storage instructions and caution to keep out of reach of children are also included.*

FDA Label Image

Glyburide-fig-1 (Glyburide Fig 1)

Chemical structure of glyburide showing its molecular formula with aromatic rings, chlorine substitution, and sulfonylurea functional groups. The structure depicts the arrangement of atoms relevant to the glyburide compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.